深圳新聞網2026年3月20日訊（記者 劉彤）“我做了自己一直想做的事，來到一個能讓自己潛心研究的地方。”中國科學院深圳先進技術研究院的一間辦公室里，戴安娜·博拉斯基教授笑說起自己與深圳的科研之緣。這位來自意大利的科學家從事免疫學研究已有50多年，科研足跡遍布歐洲、亞洲、美國等世界各地。如今在深圳光明，她繼續(xù)在生物醫(yī)學前沿領域發(fā)力，將地中海畔孕育的科學熱忱，跨越大洋融入這片面向世界的科創(chuàng)熱土。

“It allows me to do what I’ve always wanted to do, and to come to a place where I can immerse myself in research,” Professor Diana Boraschi shared her story in her office at the Shenzhen Institute of Advanced Technology. As an immunologist from Italy, she has pursued scientific research for over 50 years, with footprints across Europe, Asia, and the United States. Now based in Guangming, Shenzhen, she continues to advance research in cutting-edge fields. A passion for science, born on the shores of the Mediterranean,has crossed oceans to find a new home in this global hub of innovation.

戴安娜的“中國緣”

Diana's Connection With China

2006年，戴安娜因為一項中意合作研究項目首次來到中國。在這里，她與我國科學家一起探索基于中醫(yī)的免疫調節(jié)創(chuàng)新療法，并積極推動其他國際科研合作。2022年，她獲得了該年度的“中國政府友誼獎”，這是我國為表彰在中國現代化建設中作出突出貢獻的外國專家設立的最高榮譽。

In 2006, Diana first came to China as part of a China-Italy collaborative research project. She worked alongside Chinese scientists to explore innovative immunomodulatory therapies based on traditional Chinese medicine, actively promoting international scientific cooperation. In 2022, she was awarded the “Chinese Government Friendship Award,” the highest honor granted by the Chinese government to foreign experts who have made outstanding contributions to China’s modernization.

（圖片來源：光明科學城（公眾號））

今年2月，作為外國專家代表，戴安娜受邀在北京人民大會堂與李強總理及60位外籍專家進行了一次新春座談，為中國未來發(fā)展建言獻策?！翱偫淼难葜v十分精彩，”她回憶道，“我感到特別高興的是總理強調了中國對外開放、深化全球合作的重要性。”戴安娜也結合自身研究與觀察，在會上提出了關于生態(tài)保護、女性發(fā)展與科研傳承創(chuàng)新三個方面的建議。

This February, as a representative of foreign experts, Diana was invited to attend a Spring Festival symposium in Beijing, where she joined Premier Li Qiang and 60 other international experts to offer suggestions for China’s future development. “The Premier made a very interesting speech，” she recalled, noting that what particularly energized her was “he underlined the importance of opening China to the rest of the world.” Drawing on her own research and observations, Diana also put forward recommendations at the meeting in three areas: ecological protection, women’s development, and the contituity and innovation of scientific research.

作為傳染病領域的研究專家，戴安娜是全球科研合作的積極倡導者?！皞魅静∈遣环謬绲模瑑H僅在單一地區(qū)開展研究遠遠不夠，必須攜手合作攻克難題。”因此，對于今年深圳即將承辦的APEC會議，她也融入了自己的期待：“亞太經合組織是促進各國深入交流的重要平臺，我希望這種合作模式能推廣到全球。”她期待深圳以APEC為契機，進一步拓展全球衛(wèi)生合作，推動生物醫(yī)學研究深入發(fā)展，為解決全球性健康問題貢獻力量。

As an expert in infectious diseases, Diana is a strong advocate for global scientific collaboration. “Infectious disease that I work with do not see borders. So studying things (only) in Asia, Oceania, or in South America makes no sense. We must work together.” With this in mind, she also shared her expectations for the upcoming APEC meeting.

戴安娜對即將在光明啟用的實驗室充滿期待。她表示實驗室建設正加速推進，今年按計劃投入運營后，將會在這里開展高水平的免疫學研究。“光明是一個很年輕的行政區(qū)，給我的印象是一切都剛剛開始，新舉措、新科研機構、新企業(yè)不斷涌現?！倍劦綄饷鲄^(qū)未來五年的想象，戴安娜說出了“雙重期待”：首先是希望實驗室順利建成并投入使用，在這里持續(xù)積累免疫學研究成果；更大的愿景，是力求能研發(fā)出針對主要傳染病的疫苗，為全球醫(yī)學作出貢獻。

Diana expressed strong anticipation for the laboratory set to open soon in Guangming. She noted that construction is progressing, and once the facility becomes operational as scheduled this year, it will serve as a hub for high-level immunology research. “Guangming is a very young district,” she said. “It gave me an impression that everything is starting now. A lot of new initiatives, institutes and companies are coming up.” Looking ahead to the next five years, Diana expressed two expectations: that the laboratory will be successfully put into operation to continue advancing immunology research, and that it will help develop vaccines for major infectious diseases, contributing to global health research.

戴安娜認為，科學研究是一個長期過程，需要一步一個腳印地積累。在她眼中，光明科學城也在穩(wěn)步前行，通過建設世界級科研設施、匯聚頂尖人才，逐步構建起從實驗室到生產線的創(chuàng)新生態(tài)。這里既是一片適合潛心鉆研、實現科學理想的樂園，也是深圳開展中外科創(chuàng)交流、擁抱全球的沃土。

In Diana’s view, scientific research is a long-term endeavor that requires steady progress. From her perspective, Guangming Science City is also advancing steadily in building world-class research facilities and attracting top-tier talent, gradually establishing an innovation ecosystem that spans from the laboratory to the production line. It is both an ideal place for scientific aspirations, and fertile ground for Shenzhen to advance international scientific cooperation and original innovations.

g to be hosted in Shenzhen this year: “APEC is a way to connect people in a much better fashion, which I hope can be expanded globally.” She hopes that Shenzhen will further strengthen global health collaboration in biomedical research, contributing to the resolution of global health challenges.

選擇深圳：一個“幸運的偶然”

The "Lucky" Encounter with Shenzhen

戴安娜與深圳的結緣始于一次偶然。幾年前，她曾經在意大利指導的博士生李洋來到深圳發(fā)展，并邀請她一起來這里工作。“我很慶幸自己來了，這里的科研環(huán)境特別好。選擇來深圳是一個偶然，但可以說是一個幸運的偶然?！?/p>

Diana’s connection with Shenzhen began by chance. Several years ago, Li Yang, a former PhD student she had supervised,moved to Shenzhen for career development and invited her to join. “I’m very glad I came, and I found an excellent environment,” she said. “It was by chance, but it was a fortunate one,” she said.

目前，戴安娜擔任深圳理工大學藥學院杰出教授。她很欣賞這所大學具備的開放包容氣質，“光明區(qū)的深圳理工大學是一所新興的大學，非常年輕、開放，我認為這是它的突出優(yōu)勢，能夠吸引世界各地的人才，也便于和其他國家建立聯系、開展交流合作?！痹谒磥?，交流合作不僅是重要的科研理念，也是應對當前國際形勢的人文共識，“當今世界沖突不斷，這是由于人們之間互不理解。只有交流合作才能解決問題?！?/p>

Currently, Diana serves as a Distinguished Professor at the Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology. She greatly appreciates the university’s open and inclusive character: “It is a very young university. I think this is an advantage that can attract more people from every country to work here, and at the same time to implement active exchanges.” In her view, exchange and cooperation are not only essential scientific principles but also a shared human approach to addressing today’s global challenges. “A lot of wars and fights are going around globally, which is due to misunderstanding, and the only way of understanding is knowing each other (through active exchanges).”

正如戴安娜所說，近年來，深圳理工大學持續(xù)拓展國際科教合作，已經和24個國家和地區(qū)的52所高校建立合作關系，合作領域覆蓋了新材料、合成生物、大數據、生命健康等多個前沿方向。作為教師，戴安娜也十分看好學生在這里的發(fā)展前景，“這所以先進技術為特色的大學，與企業(yè)有著廣泛合作，學生可以更早接觸到學術之外的發(fā)展路徑，我認為這一點非常重要。”

As Diana observed, in recent years, SUAT has continuously expanded its international cooperation in science and education, establishing partnerships with 52 universities across 24 countries and regions. These collaborations span a range of cutting-edge fields, including new materials, synthetic biology and life and health sciences. As an educator, Diana is also optimistic about her students’ future development:“This university is  focusing on advanced technologies, and there are a lot of interactions with companies. So they will have many possibilities in their life.”

在光明，暢想免疫學未來

Exploring the Future of Immunology in Guangming

作為國際知名免疫學家，戴安娜在天然免疫與炎癥研究領域成果卓著。以她本人姓氏命名的“博拉斯基環(huán)”，是她發(fā)現的一段具有免疫刺激作用的白細胞介素-1（IL-1）分子結構，為免疫疾病治療、癌癥研究提供了關鍵理論支持。

As a renowned international immunologist, Diana has achieved outstanding results in the study of innate immunity and inflammation. A segment of the interleukin-1 (IL-1) molecular structure with immunostimulatory properties that she discovered was named the “Boraschi loop” after her surname, paving the way for new treatments for immune diseases and advanced cancer research.

“我有很多有意思的研究?！贝靼材茸院赖亟榻B起自己如今在深圳的科研工作。她的研究一方面聚焦于微生物與人體細胞的相互作用，探索通過調節(jié)微生物來提升人體免疫力的方法，尤其是在全球老齡化背景下，為“如何度過一個健康的老年生活”提供科學研究支持；另一方面則深入納米醫(yī)學領域，探索開展新型疫苗和靶向藥物的研發(fā)。

“I have many interesting research (projects),” Diana said with pride as she spoke about her current work in Shenzhen. Her research focuses, on the one hand, on the interaction between microorganisms and human cells, exploring ways to enhance human immunity by modulating microbes—particularly in the context of global aging, providing scientific support for the question of how to maintain a healthy life in old age. On the other hand, she is deeply engaged in the field of nanomedicine, working on the development of novel vaccines and targeted therapies.